The mitigation section below has the specifics
Journal of Nutritional Science and Vitaminology
BPC-157 is not FDA approved as a standard medication, and the FDA has identified concerns around compounded BPC-157, including possible immunogenicity risk, peptide-related impurities, and limited safety information for certain routes of administration
No clinical trial data supports this approach, and it increases your injection frequency
There is a clear need for robust trialsrobust clinical trialsto test all of this, but even if it works, its not as though everyone who needs iteven those who need it most, like a child in Flint, Michiganwill have access to a sauna
This dose is not effective for weight loss and is only intended to get your body used to the medication